Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer; Multicenter Randomized Phase 3 Study

NCT02114359 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02114359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02114359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer; Multicenter Randomized Phase 3 Study
Lead sponsor
Seoul National University Hospital
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2014
Completion date
February 29, 2020
Enrollment
111 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer